Market Research Logo

Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review

Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review

- provideides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets of a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.

Adcock Ingram Holdings Ltd Key Recent Developments

Aug 25,2016: Adcock Ingram appoints Basadifeela Letsoalo executive director
Feb 23,2016: Adcock Ingram says Dorette Neethling appointed as CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Adcock Ingram Holdings Ltd - Key Facts
Adcock Ingram Holdings Ltd - Key Employees
Adcock Ingram Holdings Ltd - Key Employee Biographies
Adcock Ingram Holdings Ltd - Major Products and Services
Adcock Ingram Holdings Ltd - History
Adcock Ingram Holdings Ltd - Company Statement
Adcock Ingram Holdings Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Adcock Ingram Holdings Ltd - Business Description
Adcock Ingram Holdings Ltd - Corporate Strategy
Adcock Ingram Holdings Ltd - SWOT Analysis
SWOT Analysis - Overview
Adcock Ingram Holdings Ltd - Strengths
Adcock Ingram Holdings Ltd - Weaknesses
Adcock Ingram Holdings Ltd - Opportunities
Adcock Ingram Holdings Ltd - Threats
Adcock Ingram Holdings Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Adcock Ingram Holdings Ltd, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Adcock Ingram Holdings Ltd, Key Facts
Adcock Ingram Holdings Ltd, Key Employees
Adcock Ingram Holdings Ltd, Key Employee Biographies
Adcock Ingram Holdings Ltd, Major Products and Services
Adcock Ingram Holdings Ltd, History
Adcock Ingram Holdings Ltd, Subsidiaries
Adcock Ingram Holdings Ltd, Joint Venture
Adcock Ingram Holdings Ltd, Key Competitors
Adcock Ingram Holdings Ltd, Ratios based on current share price
Adcock Ingram Holdings Ltd, Annual Ratios
Adcock Ingram Holdings Ltd, Annual Ratios (Cont...1)
Adcock Ingram Holdings Ltd, Annual Ratios (Cont...2)
Adcock Ingram Holdings Ltd, Interim Ratios
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Adcock Ingram Holdings Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Adcock Ingram Holdings Ltd, Performance Chart (2013 - 2017)
Adcock Ingram Holdings Ltd, Ratio Charts
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report